Skip to main content
logo
Opus Genetics, Inc. (FRA:R3X1)
Germany flag Germany · Delayed Price · Currency is EUR
2.850
-0.165 (-5.47%)
At close: Feb 20, 2026

Opus Genetics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
14.6310.9919.0539.850.59-
Revenue Growth (YoY)
74.60%-42.30%-52.20%6665.70%--
Cost of Revenue
27.4226.8517.6514.3615.176.65
Gross Profit
-12.79-15.861.425.5-14.58-6.65
Selling, General & Admin
24.3918.2211.967.278.122.82
Operating Expenses
24.3918.2211.967.278.122.82
Operating Income
-37.18-34.07-10.5618.23-22.71-9.47
Interest Expense
-0.07--1.33-0.01-0-6.85
Interest & Investment Income
1.421.80.160-
Currency Exchange Gain (Loss)
----0--
Other Non Operating Income (Expenses)
-4.362.560.15--33.83-1.48
EBT Excluding Unusual Items
-40.2-29.52-9.9418.37-56.53-17.79
Gain (Loss) on Sale of Investments
-0-0.01-0.03-0.17-0.07-
Other Unusual Items
-----0.093.67
Pretax Income
-68.2-57.53-9.9718.2-56.69-24.62
Income Tax Expense
--0.010.32--
Net Income
-68.2-57.53-9.9917.89-56.69-24.62
Net Income to Common
-68.2-57.53-9.9917.89-56.69-24.62
Shares Outstanding (Basic)
50272220155
Shares Outstanding (Diluted)
50272221155
Shares Change (YoY)
99.64%23.74%4.82%38.68%218.65%63.84%
EPS (Basic)
-1.37-2.15-0.460.90-3.82-5.28
EPS (Diluted)
-1.37-2.15-0.460.87-3.82-5.28
Free Cash Flow
-32.86-25.58-1.1114.31-19.47-8.27
Free Cash Flow Per Share
-0.66-0.96-0.050.69-1.31-1.77
Gross Margin
-87.37%-144.28%7.33%63.98%--
Operating Margin
-254.05%-309.99%-55.45%45.74%-3854.84%-
Profit Margin
-466.09%-523.40%-52.42%44.89%-9625.30%-
Free Cash Flow Margin
-224.55%-232.68%-5.84%35.92%-3305.60%-
EBITDA
-37.13-34.06-10.5618.23-22.7-9.46
EBITDA Margin
-253.74%--55.42%45.75%--
D&A For EBITDA
0.050.010.01000.01
EBIT
-37.18-34.07-10.5618.23-22.71-9.47
EBIT Margin
-254.05%--55.45%45.74%--
Effective Tax Rate
---1.73%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.